Lin C - Search Results

1

Combining anti-IgE with oral immunotherapy.

Lin C, Lee IT, Sampath V, Dinakar C, DeKruyff RH, Schneider LC, Nadeau KC. Lin C, et al. Pediatr Allergy Immunol. 2017 Nov;28(7):619-627. doi: 10.1111/pai.12767. Epub 2017 Sep 7. Pediatr Allergy Immunol. 2017. PMID: 28782296 Review.

2

Impact of allergen immunotherapy in allergic asthma.

Zhang W, Lin C, Sampath V, Nadeau K. Zhang W, et al. Among authors: lin c. Immunotherapy. 2018 Jun;10(7):579-593. doi: 10.2217/imt-2017-0138. Epub 2018 Mar 23. Immunotherapy. 2018. PMID: 29569506 Free PMC article. Review.

3

Involving degradation products provides a new perspective of diffuse pollution assessment of atrazine with a modified mass balance approach.

Guo Z, Ouyang W, He M, Peng S, Hu J, Lin C. Guo Z, et al. Among authors: lin c. J Hazard Mater. 2025 Jan 9;487:137169. doi: 10.1016/j.jhazmat.2025.137169. Online ahead of print. J Hazard Mater. 2025. PMID: 39799676

4

Mapping essential oral healthcare for the Australian context.

Nguyen TM, Lin C, Hall M, Calache H. Nguyen TM, et al. Among authors: lin c. Aust Health Rev. 2025 Jan 13. doi: 10.1071/AH24298. Online ahead of print. Aust Health Rev. 2025. PMID: 39800485

5

Antibody-drug conjugates targeting SSEA-4 inhibits growth and migration of SSEA-4 positive breast cancer cells.

Usama M, Hsu YC, Safaei M, Chen CY, Han KH, Ho YS, Yamaguchi H, Li YC, Hung MC, Wong CH, Lin CW. Usama M, et al. Among authors: lin cw. Cancer Lett. 2025 Jan 9:217453. doi: 10.1016/j.canlet.2025.217453. Online ahead of print. Cancer Lett. 2025. PMID: 39798832

6

Possible role of autophagy in microbial volatile pollutant-induced starch degradation and expression of hypoxia responsive genes.

Huang CC, Chang CH, Thi Truong TT, Wang WG, Lin CH, Chiang CY, Obayashi I, Huang HJ. Huang CC, et al. Among authors: lin ch. Environ Pollut. 2025 Jan 9:125663. doi: 10.1016/j.envpol.2025.125663. Online ahead of print. Environ Pollut. 2025. PMID: 39798790

7

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.

Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 8:S0140-6736(24)02551-0. doi: 10.1016/S0140-6736(24)02551-0. Online ahead of print. Lancet. 2025. PMID: 39798579

8

Formative evaluation of a mobile chat-based intervention (ChatEx) for promoting exercise behaviour in older cancer survivors.

Ting Cheung DS, Chan CK, Rhodes RE, Chau PH, Chiang CL, Tse M, Wang MP, Yu DSF, Lin CC. Ting Cheung DS, et al. Among authors: lin cc. Eur J Oncol Nurs. 2024 Dec 21;74:102774. doi: 10.1016/j.ejon.2024.102774. Online ahead of print. Eur J Oncol Nurs. 2024. PMID: 39798519

9

Chiral recognition of CIAC001 isomers in regulating pyruvate kinase M2 and mitigating neuroinflammation.

Jin S, Wang X, Zhou X, Wu S, Tang Y, Jiang P, Xu H, Zhang W, Wang Y, Wang H, Lin C, Wang X. Jin S, et al. Among authors: lin c. Eur J Med Chem. 2025 Jan 7;285:117262. doi: 10.1016/j.ejmech.2025.117262. Online ahead of print. Eur J Med Chem. 2025. PMID: 39798402

10

Environmentally friendly inhaler regimens for COPD.

Wang MT, Lin CW. Wang MT, et al. Among authors: lin cw. BMJ. 2024 Dec 30;387:q2825. doi: 10.1136/bmj.q2825. BMJ. 2024. PMID: 39797804 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,943 results

Search Page

Filters